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Abstract
Introduction
Non-citizens often face barriers to HIV care and treatment. Quantifying knowledge of posi-
tive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-
prevalence country like Botswana that is close to achieving UNAIDS “90-90-90” targets may
expose important gaps in achieving universal HIV testing and treatment.
Methods
The Botswana Combination Prevention Project (BCPP) is a pair-matched cluster-random-
ized trial evaluating the impact of prevention interventions on HIV incidence in 30 rural or
peri-urban communities. Community case finding and HIV testing were conducted in home
and mobile venues in 15 intervention communities from October 2013-September 2017. In
this secondary analysis, we compared HIV positivity, knowledge of positive HIV-status, and
ART status among all citizens and non-citizens assessed at intake in the intervention
communities.
Results
HIV status was assessed in 57,556 residents in the intervention communities; 4% (n =
2,463) were non-citizens. Five communities accounted for 81% of the total non-citizens
assessed. A lower proportion of non-citizens were HIV-positive (15%; n = 369) compared to
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citizens (21%; n = 11,416) [p = 0.026]; however, a larger proportion of non-citizens did not
know their HIV-positive status prior to BCPP testing (75%) as compared to citizens (15%) [p
= 0.003]. Among residents with knowledge of their HIV-positive status before BCPP, 79% of
the non-citizens (72/91) were on ART compared to 86% (8,267/9,652) of citizens (p =
0.137).
Conclusions
Although non-citizens were less likely to know their HIV-positive status compared to citi-
zens, there were no differences in treatment uptake among non-citizens and citizens who
knew their status. Designing interventions for non-citizens that provide HIV testing and treat-
ment services commensurate to that of citizens as well as targeting communities with the
largest number of non-citizens may help close a meaningful gap in the HIV care cascade
and ensure ethical treatment for all HIV-positive persons.
Trial registration
ClinicalTrials.gov: NCT01965470 (Botswana Combination Prevention Project).
Introduction
Knowing one’s positive HIV status and initiating and staying on treatment are essential for
combatting the HIV epidemic. The UNAIDS “90-90-90” targets establish goals for 90% of all
HIV-infected persons to know their status, 90% of persons with diagnosed HIV infection to
receive sustained antiretroviral therapy (ART), and 90% of all persons receiving ART to be
virally suppressed by 2020 [1]. Achieving the “90-90-90” targets and scaling up to “95-95-95”
by 2030 is projected to reduce HIV incidence and mortality by 90% compared to 2010 levels
[2].
Botswana, a high HIV prevalence country with 22.8% of its adult population infected with
the HIV virus [3], is currently on target to reach the “90-90-90” targets [3, 4]. With strong
political will and leadership, Botswana was one of the first countries with a generalized HIV
epidemic to commit to a national HIV treatment program and one of the first African coun-
tries to offer free HIV testing and adopt a universal treatment policy regardless of CD4+ T-cell
count [5]. The ART program, in place since 2002, provides free HIV care and treatment ser-
vices to Botswana citizens. Despite the great strides that the country has made in the HIV epi-
demic response, incident cases are still being reported in the country [6, 7]. Little research has
been conducted in Botswana to determine if coverage of the HIV treatment cascade extends
across sub-populations who may have less access to health care.
One subpopulation in Botswana who may not be adequately covered by the HIV care cas-
cade is the non-citizen population that is currently residing in the country. Migratory sub-pop-
ulations may experience poor health outcomes and contribute to the ongoing epidemic
because of reduced access to HIV testing and treatment programs designed to serve their
unique needs [8]. Botswana attracts migrant workers and shares close proximity to bordering
countries (South Africa, Zambia and Zimbabwe) with high HIV prevalence [4]. In 2015, it was
estimated that there were 161,000 non-citizens in Botswana representing about 7% of the total
population of 2.3 million people [9]. Current Botswana policy offers free health services and
ART to all citizens and spouses of citizens but requires payment for these same services from
non-citizens who are currently living and working in the country.
Non-citizens and Botswana’s HIV care program
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The largest cities in Botswana attracting migrant labor are geographically close to the afore-
mentioned neighboring countries with high HIV prevalence. Migrant workers becoming
infected upon reaching Botswana may be less willing to access HIV testing given that they are
not eligible for free treatment. In addition, HIV-positive non-citizens receiving treatment in
their country of origin may be unlikely to return for prescription refills and ongoing health care
and, thus, are at risk for developing drug resistance. Consequently, Botswana may have a sub-
stantial group of people not receiving WHO and UNAIDS recommended universal HIV testing
and treatment to reduce mortality among infected persons and to promote epidemic control.
There are limited data on the extent of HIV infection within the non-citizen population in
Botswana [10], and the extent to which HIV-positive persons are receiving essential HIV-
related health services. Through a sub-analysis we sought to quantify differences in HIV-posi-
tivity, HIV testing and knowledge of status, and ART coverage between citizens and non-citi-
zens as a means to further understand the implications for reaching the 90-90-90 targets and
HIV epidemic control in Botswana.
Methods
Design
The Botswana Combination Prevention Project (BCPP) is a cluster-randomized HIV preven-
tion trial evaluating the impact of a package of prevention interventions on population-level
HIV incidence in 30 rural or peri-urban communities in Botswana with an average population
of 6,000 per community. Fifteen communities were randomly assigned to the intervention
arm and 15 to the arm receiving standard of care services. A full description of the study design
is available elsewhere [11]. HIV and ART status were assessed among residents in the 15 inter-
vention communities from October 2013-September 2017. Secondary analyses of data col-
lected at intake from the intervention communities only are presented here. Information on
non-citizens was not collected in the 15 control communities.
Participants
All community residents 16–64 years old were interviewed and assessed for HIV status after
providing verbal consent as per Botswana’s HIV testing guidelines for anyone aged�16 years.
[12]. Community residency was established through self-report and defined as spending at least
three nights per month in the community. Persons were classified as citizens if they had an
Omang (national identifier) or Botswana passport. Non-citizenship was self-reported, and pass-
port numbers were collected if available. All persons were asked if they had ever tested HIV-
positive. Those who knew their HIV-positive status were asked for documentation of HIV sta-
tus. Persons who did not know their HIV status, who did not have documentation of an HIV-
positive status, or who did not have documentation of a negative HIV test within the preceding
three months were offered HIV testing. All HIV testing and data collection were conducted by
trained local lay counselors who were fluent in Setswana, English and other local languages.
Setting and procedures
Community campaigns composed of both home and mobile testing strategies were employed
to reach all community residents aged 16–64 years. For the home-based strategy, counselors
received lists of all household plots for each of the intervention communities (obtained from
Google maps and Botswana 2011 census data). GPS coordinates were used to locate the house-
holds on handheld tablets. Counselors returned to households up to three times in order to
find residents at home for assessment of HIV status and HIV testing if indicated. The study
Non-citizens and Botswana’s HIV care program
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teams conducted evening and weekend HIV testing and made appointments for home-based
testing for times when absent residents would be home. Mobile testing was made available
throughout communities at high traffic locations including markets and transport hubs. In
addition, mobile testing was provided at community events, health fairs, work sites and she-
beens/bars. Persons accessing mobile venues completed the same study procedures as persons
participating in the home. All HIV infected persons not on ART identified in home or mobile
venues were counseled on the benefits and importance of early care and treatment for their
health and the health of partners and children.
Data collection, variable measurement, and analyses
Data collection. All responses to structured interview questions and results of HIV tests
were collected on encrypted handheld tablets, which were synchronized daily with the research
database and removed from the tablet after synchronization to maximize data confidentiality.
For field-based rapid HIV testing, finger stick testing using Unigold (Trinity Biotech, Wick-
low, Ireland) and KHB (Shanghai Kehua Bio-engineering Co Ltd, Shanghai, China) tests was
conducted following the Botswana national testing algorithm. Quality control was assured by
re-testing samples from each community in the reference laboratory using enzyme-linked
immunosorbent assay (ELISA) and HIV-1 Western Blot testing.
Measurement of study variables. Algorithms were designed to measure three main out-
comes: HIV positivity, knowledge of positive HIV status prior to BCPP, and ART coverage.
1. HIV-positive status was defined as a positive result on an HIV test conducted through
BCPP or documentation of HIV positivity at intake (i.e., previous positive test result, health
card, ART pill bottle, or electronic medical record) of unique individuals found in either
home or mobile venues.
2. Knowledge of positive HIV status prior to BCPP intake was defined as the show of docu-
mentation of HIV positivity prior to BCPP interview date (i.e., test result, health card, ART
pill bottle, or electronic medical record).
3. Current on ART was defined by documentation of current use of ART (health cards, pre-
scriptions, pill bottles, electronic medical records) at the time of BCPP intake.
Analysis. SAS 9.4 was used for all statistical analyses. SAS PROC SURVEYFREQ was used
to produce frequencies adjusting for clustering of observations within communities. Bivariate
tests of association were conducted using Rao-Scott Chi-square tests, with a critical alpha level
of 0.05. SAS PROC SURVEYLOGISTIC was used to test for association between sociodemo-
graphic factors of interest and HIV positivity, prior knowledge of HIV-positive status and
ART status. These models produced unadjusted and adjusted odds ratios (ORs) and 95% con-
fidence limits.
Ethics approval. The study was approved by the Centers for Disease Control and Preven-
tion Institutional Review Board (Protocol #6475) and the Botswana Health Research and
Development Committee (Institutional Review Board of the Botswana Ministry of Health and
Wellness). The study was monitored by an Independent Data and Safety Monitoring Board.
Results
Characteristics of persons assessed for HIV status
BCPP interviewed 60,139 residents in the intervention communities. Among those inter-
viewed, HIV status was ascertained in 96% (n = 57,556) of residents (53% female, 47% male)
Non-citizens and Botswana’s HIV care program
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with only 4% refusing to be tested or show documentation of their HIV status. Overall, 4%
(n = 2463) of the assessed residents self-reported as non-citizens. The refusal rate among non-
citizens was higher than the refusal rate among citizens (6% vs. 4%; p = 0.028).
Table 1 displays characteristics comparing non-citizens to citizens. A higher proportion of
non-citizens were male (64%) compared to the proportion of citizens (46%; p = 0.001). The
average age among non-citizens was slightly younger compared to citizens with the greatest
proportion of non-citizens falling between the ages of 25–34 and the greatest proportion of cit-
izens falling between the ages of 35–64 (p = 0.002). Non-citizens were more likely to be
assessed in mobile venues (65%) compared to citizens (51%; p = 0.009).
HIV-positive status
Among all residents assessed, 21% (n = 11,785) were HIV-positive. Non-citizens represented
3% (n = 369) of all HIV-positives identified. Five of the 15 communities (Masunga, Mathang-
wane, Nkange, Oodi and Tati Siding) accounted for 83% of the HIV-positive non-citizens
identified. Four out of five of communities were located just outside of Francistown, the sec-
ond largest city in Botswana, which is close to the border of Zimbabwe. The proportion of resi-
dents who were HIV-positive ranged from 9% to 28% across communities among non-
citizens and 14% to 29% among citizens.
A smaller proportion of non-citizens were HIV-positive (15%; n = 369) as compared to citi-
zens (21%; n = 11,416) [p = 0.026]. Table 2 presents bivariate analyses of characteristics of per-
sons who were HIV-positive among those assessed. A smaller proportion of the HIV-infected
non-citizens were female compared to citizens (48% vs. 66%; p = 0.001). A significantly higher
proportion of HIV-positive non-citizens (46%) were identified in mobile venues as compared
to citizens (22%) [p = 0.016]. In a multivariate analysis, citizenship remained associated with
HIV positivity; non-citizens were 20% less likely to be HIV infected compared to citizens after
controlling for age, sex, and peri-urban vs. rural community of residence (Table 3).
Prior knowledge of HIV status
Of the 11,785 HIV positive persons identified, 83% (n = 9,743) had documentation of being
HIV-positive and 17% (n = 2,042) tested HIV-positive in BCPP. A significantly smaller pro-
portion of non-citizens knew their HIV-positive status prior to BCPP testing (25%) than did
Table 1. Demographic characteristics and testing venues of individuals assessed for HIV status.
Variable Non-citizens (N = 2,463)
n (%)
Citizens (N = 55,093)
n (%)
P-value�
Sex <0.001
Female 885 (36) 29,802 (54)
Male 1,578 (64) 25,291 (46)
Age (in years) 0.002
16–24 606 (25) 17,360 (32)
25–34 1,059 (43) 16,344 (30)
35–64 798 (32) 21,389 (39)
Testing Venue 0.009
Assessed in Home 851 (35) 27,201 (49)
Assessed in Mobile unit 1,612 (65) 27,892 (51)
Values are presented as frequency (%).
� p value calculated using the Rao-Scott modified Chi square test
https://doi.org/10.1371/journal.pone.0221629.t001
Non-citizens and Botswana’s HIV care program
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citizens (85%; p = 0.003). Table 4 displays the multivariate analysis of selected sociodemo-
graphic factors and prior knowledge of HIV-positive status. Non-citizens were 93% less likely
to know their HIV positive status at intake compared to citizens adjusting for sex, age, and
rural vs. peri-urban community (p<0.001).
Currently on ART
Among all HIV-positives, 71% (8,339/11,785) were currently on ART. Among HIV-positive
non-citizens who knew their status prior to BCPP, 79% (72/91) were on ART compared to
86% (8,267/9,652) of citizens with prior knowledge of their HIV status (p = 0.137). Table 5 dis-
plays the multivariate analysis between selected sociodemographic factors and ART status
among those with prior knowledge of their HIV-positivity. Citizenship was not related to
being on ART among persons who knew their positive status (p = 0.38).
Table 2. Characteristics of HIV-Positive Non-Citizens and Citizens.
Variable HIV+ Non-citizens (N = 369)
n (%)
HIV+ Citizens (N = 11,416)
n (%)
P-value �
Sex 0.001
Female 176 (48) 7,586 (66)
Male 193 (52) 3,830 (34)
Age (in years) <0.001
16–24 43 (12) 965 (8)
25–34 145 (39) 2,702 (24)
35–64 181 (49) 7,749 (68)
Testing venue 0.016
HIV+ in Home 198 (54) 8,958 (78)
HIV+ in Mobile unit 171 (46) 2,458 (22)
Values are presented as frequency (%).
� P-value calculated using the Rao-Scott modified Chi square test.
https://doi.org/10.1371/journal.pone.0221629.t002
Table 3. Association of sociodemographic variables with HIV infection, n = 57,556.
Variable Unadjusted OR
(95% CI)
p Adjusted OR
(95% CI)
p
Sex
Female 1.92 (1.80, 2.06) <0.001� 1.98 (1.83, 2.13) <0.001�
Male ref — ref —
Age
16–24 0.11 (0.09, 0.12) <0.001� 0.11 (0.09, 0.12) <0.001�
25–34 0.35 (0.31, 0.39) <0.001� 0.36 (0.32, 0.40) <0.001�
35–49 ref — ref —
Citizenship
Non-citizen 0.68 (0.55, 0.83) 0.001� 0.80 (0.66, 0.96) 0.02�
Citizen of Botswana ref — ref —
Community residency
Peri-urban 0.86 (0.63, 1.19) 0.34 0.93 (0.67, 1.27) 0.61
Rural ref — ref —
�Significant at α = .05
https://doi.org/10.1371/journal.pone.0221629.t003
Non-citizens and Botswana’s HIV care program
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Discussion
The results presented in this paper offer insight into the HIV epidemic among non-citizen res-
idents of Botswana and the gaps in coverage of vital HIV services for individual health and epi-
demic control. Among residents assessed, HIV positivity among non-citizens was 15%. Only
25% of HIV-positive non-citizens knew their HIV status and thus the vast majority of non-citi-
zens were not receiving treatment. Among non-citizens who knew their positive status, 79%
were receiving ART, a percentage similar to ART use among citizens (86%). In sum, these
findings suggest that this important sub-population in Botswana has substantial need for HIV
services but is critically underserved.
Table 4. Association of sociodemographic variables with prior knowledge of HIV-positive status among those assessed as HIV-positive, n = 11,785.
Variable Unadjusted OR
(95% CI)
p Adjusted OR
(95% CI)
p
Sex
Female 2.25 (2.06, 2.45) <0.001� 2.72 (2.46, 2.99) <0.001�
Male ref — ref —
Age
16–24 0.24 (0.19, 0.29) <0.001� 0.19 (0.15, 0.24) <0.001�
25–34 0.40 (0.35, 0.46) <0.001� 0.36 (0.32, 0.40) <0.001�
35–49 ref — ref —
Citizenship
Non-citizen 0.06 (0.04, 0.08) <0.001� 0.07 (0.05, 0.10) <0.001�
Citizen of Botswana ref — ref —
Community residency
Peri-urban 0.64 (0.42, 0.97) 0.04 0.78 (0.51, 1.18) 0.22
Rural ref — ref —
�Significant at α = .05
https://doi.org/10.1371/journal.pone.0221629.t004
Table 5. Association of sociodemographic variables to ART use among persons who had prior knowledge of HIV-positive status, n = 9,743.
Variable Unadjusted OR
(95% CI)
p Adjusted OR
(95% CI)
p
Sex
Female 0.97 (0.86, 1.09) 0.56 1.13 (1.00, 1.27) 0.05
Male ref — ref —
Age
16–24 0.42 (0.35, 0.51) <0.001� 0.42 (0.35, 0.50) <0.001�
25–34 0.43 (0.38, 0.48) <0.001� 0.42 (0.37, 0.48) <0.001�
35–49 ref — ref —
Citizenship
Non-citizen 0.63 (0.31, 1.30) 0.19 0.75 (0.38, 1.48) 0.38
Citizen of Botswana ref — ref —
Community residency
Peri-urban 0.74 (0.56, 0.97) 0.03� 0.75 (0.57, 0.98) 0.04�
Rural ref — ref —
�Significant at α = .05
https://doi.org/10.1371/journal.pone.0221629.t005
Non-citizens and Botswana’s HIV care program
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Data from extensive community-based HIV case finding and testing services showed that
non-citizens accounted for 4% of the overall population in the 15 intervention communities.
However, five communities accounted for 81% of the non-citizens assessed and 83% of the
positive non-citizens identified. These findings suggest that HIV interventions for this sub-
population should be targeted to specific geographic locations which are most likely to attract
migrant labor and/or refugees.
Botswana offers free HIV testing to non-citizens, but at BCPP intake only 25% of non-citi-
zens knew they were HIV-positive compared to 85% of citizens. Non-citizens may not proac-
tively seek HIV testing for a myriad of reasons related to their immigration status including
disrupted living situations, lack of support from family members, negative attitudes of health-
care workers, fear of deportation, stigma, and lack of availability of HIV treatment even if they
know their status. Evidence in other studies have shown similar factors to be challenges for
immigrants accessing healthcare in Southern Africa [13,14].
Despite the low level of knowledge of HIV status at intake, 94% percent of non-citizens
offered an HIV test consented to testing, and many sought testing services in mobile venues.
More non-citizens were assessed in mobile venues than in the home, but more HIV-positive
non-citizens were identified in the home. These findings suggest that non-citizens are recep-
tive to HIV testing, and both home and mobile testing services reach a high proportion of
non-citizens so should be part of the testing strategy for reaching this group.
Unlike the HIV-positive citizens, the majority of HIV-positive non-citizens were not on
ART when first encountered by BCPP. Treatment options are likely cost-prohibitive for many
within this group and they are not eligible for government-subsidized ART. Thus, the health
of HIV-positive non-citizens is probably greatly compromised and viral suppression coverage
in the community as a whole is unattainable. If non-citizens access ART in their countries of
origin and experience treatment interruptions due to cost when they migrate, this may intro-
duce drug mutations with implications if the resistant virus is further transmitted.
In the Southern African Development Community (SADC) that includes Botswana, there
are concerns that the HIV response in the region does not adequately address the movement
of healthcare users within and between countries thereby impacting universal test and treat
programs[13]. In a region most impacted by HIV, comprehensive, sustainable, and inclusive
programs are required. Addressing potential pockets of undiagnosed HIV in subpopulations
may improve health outcomes of these groups and reduce continued occurrence of new HIV
infections.
Several methodological limitations existed within the study. Measuring the non-citizens’
knowledge of positive HIV status prior to the BCPP intervention was limited to the individu-
al’s ability to produce documentation of a prior HIV test result. Without the government-
issued Omang, the study team was unable to obtain any clinical data on HIV testing and ART
status for non-citizens using a unique identifier as was possible with the citizen group. Clinical
records (e.g., HIV test results occurring before the interview date, ART initiation dates prior to
the interview, etc.) were used to augment the documentation of intake data among the citizens
but unavailable for the non-citizens. Therefore, it is possible that a higher proportion of non-
citizens were “known HIV-positive” at intake than reported. Another methodological limita-
tion to the study was that BCPP was conducted in rural and peri-urban communities and not
the larger cities which serve as economic hubs and typically draw immigrants seeking work in
Botswana. Therefore, rural/peri-urban communities may not be representative of where most
non-citizens reside in Botswana. This design feature could explain the difference between the
estimated 7% non-citizen population in Botswana and BCPP’s report of 4% non-citizenship
among all community residents assessed for HIV. Thus, the HIV positivity and treatment rates
found among non-citizens may or may not be generalizable to the country as a whole.
Non-citizens and Botswana’s HIV care program
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Conclusions
Non-citizens have lower levels of knowledge of positive HIV status compared to citizens; thus,
overall ART coverage is low in this sub-population in Botswana. When they know their HIV-
positive status, rates of ART uptake are similar among citizens and non-citizens. In a country
close to achieving their “90-90-90” goals but still reporting new HIV infections, it is imperative
to examine gaps in the HIV care cascade at a sub-population level. Increasing access to HIV
care by eliminating social and monetary barriers for non-citizens may improve health outcomes
for all and possibly contribute to epidemic control in Botswana. Focusing intervention efforts
on the geographic locations where most non-citizens reside may produce the greatest benefit.
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